On a semi-annual basis, ACCP Staff & Leadership assess progress against the 2021 – 2025 Strategic Plan to ensure that society goals and objectives are being met. ACCP remains committed to its core Mission & Vision, including developing new educational events and formats to meet the needs identified by Members. The tactical implementation of various elements within the Strategic Plan has resulted in ACCP continuing to exceed a series of nonprofit benchmarks indicating that organizational processes are on the mark for success and strong sustainability. Outreach is achieved effectively through the ACCP Ambassador Program, the publication of a series of Public Policy manuscripts, joint educational events with other entities, membership presentations about careers in clinical pharmacology and webinars to support Students, Trainees & Early-stage Professionals. In summary, we are pleased to report that the 2023 semi-annual assessment of the Strategic Plan overall met or succeeded the indicator goals and we look forward to continuing our focused efforts to meet the goals and objectives of the plan.

The ACCP Leadership Development Program is a six-month program that provides a structured experience for individual professional growth in the global clinical pharmacology community as well as a pipeline of potential future ACCP Leaders. Best of luck to the 2024 Leadership Development Program participants Elham Amini, PharmD, PhD, Junghwa Park, PharmD, Arun Ram MD, LMCC, FCP, Ravi Shankar Singh, PhD, FCP and Elijah Weber, PhD! We look forward to your continued support of ACCP and the clinical pharmacology community.

The American College of Clinical Pharmacology® (ACCP) proudly announced the appointment of Dr. John N. van den Anker, MD, PhD, FAAP, FCP, as the new Editor-in-Chief of The Journal of Clinical Pharmacology (JCP). A distinguished neonatal and pediatric clinical pharmacologist, Dr. van den Anker currently holds the Evan and Cindy Jones Endowed Chair of Pediatric Clinical Pharmacology at Children’s National Hospital in Washington, DC.

With a decade of service on the JCP Editorial Board and an extensive record of publishing, Dr. van den Anker brings unparalleled expertise to his new role. His active involvement in ACCP since 2002 includes key positions such as Regent, Secretary, President and Councilor, showcasing his commitment to advancing clinical pharmacology.

We kindly thank those who have already paid and whose sustained membership supports ACCP’s Mission & Vision as it also provides them opportunities for professional growth and development.

Thank you to all who submitted nominations during ACCP's Call for Nominations for the Board of Regents. The Nominating Committee serves to evaluate the nominees and the slate of candidates will be presented for an election in June 2024

The Newest ACCP Webinar:

The ACCP Early-stage Professionals Webinar Series:

View the entire list of STEP & ESP webinars.